The identification and characterisation of gene abnormalities underlying FHH and ADH have led to the delineation of a parathyroid and renal G protein-coupled Ca2+o-sensing mechanism, which involves the CaSR, Gα11 and AP2σ proteins. The gene discussed is GNA11; the disease is familial hypocalciuric hypercalcemia.